Search research articles
Contact Us
Filters
Showing results (31-40 of 80) with videos related to
Page
of 8
Sort By:
European Journal of Immunology
|
August 30, 2012
Genetic ablation of PI3Kγ results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels
Stephanie J Harris, Loredana Ciuclan, Peter M Finan, et al.
Neuropharmacology
|
October 18, 2019
Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD
Elisabeth Singer, Carolin Walter, Doriano Fabbro, et al.
FEBS Letters
|
November 24, 2004
The direct effect of leptin on skeletal muscle thermogenesis is mediated by substrate cycling between de novo lipogenesis and lipid oxidation
Giovanni Solinas, Serge Summermatter, Davide Mainieri, et al.
Science Signaling
|
July 20, 2017
PI3Kγ activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity
Ludovic Breasson, Barbara Becattini, Claudia Sardi, et al.
Immunology
|
August 30, 2008
Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation
Matthew Thomas, Matthew J Edwards, Elzbieta Sawicka, et al.
Elife
|
March 4, 2021
Disease-related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors
Manoj K Rathinaswamy, Zied Gaieb, Kaelin D Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 28, 2011
PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance
Barbara Becattini, Romina Marone, Fabio Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2009
Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma
Barbara Kurig, Aliaksei Shymanets, Thomas Bohnacker, et al.
Molecular Cancer Research : MCR
|
April 18, 2009
Targeting melanoma with dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors
Romina Marone, Dominik Erhart, Ann C Mertz, et al.
ACS Medicinal Chemistry Letters
|
October 18, 2019
Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety
Chiara Borsari, Denise Rageot, Florent Beaufils, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 80) with videos related to
Sort By:
Page
of 8
European Journal of Immunology
|
August 30, 2012
Genetic ablation of PI3Kγ results in defective IL-17RA signalling in T lymphocytes and increased IL-17 levels
Stephanie J Harris, Loredana Ciuclan, Peter M Finan, et al.
Neuropharmacology
|
October 18, 2019
Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD
Elisabeth Singer, Carolin Walter, Doriano Fabbro, et al.
FEBS Letters
|
November 24, 2004
The direct effect of leptin on skeletal muscle thermogenesis is mediated by substrate cycling between de novo lipogenesis and lipid oxidation
Giovanni Solinas, Serge Summermatter, Davide Mainieri, et al.
Science Signaling
|
July 20, 2017
PI3Kγ activity in leukocytes promotes adipose tissue inflammation and early-onset insulin resistance during obesity
Ludovic Breasson, Barbara Becattini, Claudia Sardi, et al.
Immunology
|
August 30, 2008
Essential role of phosphoinositide 3-kinase gamma in eosinophil chemotaxis within acute pulmonary inflammation
Matthew Thomas, Matthew J Edwards, Elzbieta Sawicka, et al.
Elife
|
March 4, 2021
Disease-related mutations in PI3Kγ disrupt regulatory C-terminal dynamics and reveal a path to selective inhibitors
Manoj K Rathinaswamy, Zied Gaieb, Kaelin D Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
September 28, 2011
PI3Kγ within a nonhematopoietic cell type negatively regulates diet-induced thermogenesis and promotes obesity and insulin resistance
Barbara Becattini, Romina Marone, Fabio Zani, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 13, 2009
Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma
Barbara Kurig, Aliaksei Shymanets, Thomas Bohnacker, et al.
Molecular Cancer Research : MCR
|
April 18, 2009
Targeting melanoma with dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitors
Romina Marone, Dominik Erhart, Ann C Mertz, et al.
ACS Medicinal Chemistry Letters
|
October 18, 2019
Preclinical Development of PQR514, a Highly Potent PI3K Inhibitor Bearing a Difluoromethyl-Pyrimidine Moiety
Chiara Borsari, Denise Rageot, Florent Beaufils, et al.
Page
of 8